Skip to main content
BIODYNE CO., LTD. logo

BIODYNE CO., LTD. — Investor Relations & Filings

Ticker · 314930 ISIN · KR7314930009 KO Manufacturing
Open in API
Filings indexed 118 across all filing types
Latest filing 2024-09-12 Director's Dealing
Country KR South Korea
Listing KO 314930

About BIODYNE CO., LTD.

https://biodyne.co.za/

BIODYNE CO., LTD. is a developer and manufacturer of medical devices, reagents, and consumables specializing in cancer diagnosis solutions. The company's core offering is the PATHPLORER Liquid-Based Cytology (LBC) system, which includes fully automatic cell preparation instruments and associated diagnostic kits. A key differentiator is its patented 'Blowing Technology,' a unique method for cell preparation in LBC diagnostics, which the company pioneered. BIODYNE focuses on providing advanced solutions for cytopathology to improve the accuracy and efficiency of disease screening.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share transactions (purchases) made by a company director (Go Yu-ra) of Biodyne. This is a standard regulatory filing for insider trading/director dealings in the Korean market, which corresponds to the 'Director's Dealing' category.
2024-09-12 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report of Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is a standard regulatory requirement for directors or major shareholders to disclose changes in their personal shareholdings (insider trading). Based on the provided definitions, this falls under 'Director's Dealing' (DIRS).
2024-09-12 Korean
반기보고서 (2024.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for the company '바이오다인' covering the period from January 1, 2024, to June 30, 2024. It contains detailed financial information, business descriptions, and management reports, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2024
2024-08-14 Korean
분기보고서 (2024.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'Biodyne' (주식회사 바이오다인) covering the period from January 1, 2024, to March 31, 2024. It contains detailed financial information, business operations, management discussions, and capital structure updates, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2024
2024-05-16 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the acquisition of shares by a newly appointed executive (Go Yu-ra) of Biodyne. This is a standard regulatory filing for insider trading/shareholding disclosure, which corresponds to the 'Director's Dealing' category.
2024-04-01 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed by an executive (Yang Geun-ho) of Biodyne. This type of filing is a standard regulatory disclosure for insider trading or changes in share ownership by company directors/executives, which corresponds to the 'Director's Dealing' category.
2024-04-01 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.